{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:34:01Z","timestamp":1787614441645,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.annepidem.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T04:45:36Z","timestamp":1632458736000},"page":"102-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["The spatiotemporal distribution of pre-exposure prophylaxis accessibility in the United States, 2016\u20132020"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1898-6202","authenticated-orcid":false,"given":"J. Danielle","family":"Sharpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie L.","family":"Guest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5553-7540","authenticated-orcid":false,"given":"Aaron J.","family":"Siegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis H.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.annepidem.2021.09.006_bib0001","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV epidemic: a plan for the United States","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.annepidem.2021.09.006_bib0002","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2105\/AJPH.2019.305380","article-title":"The time is now to end the HIV epidemic","volume":"110","author":"Giroir","year":"2020","journal-title":"Am J Public Health"},{"issue":"9839","key":"10.1016\/j.annepidem.2021.09.006_bib0003","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0140-6736(12)61235-5","article-title":"FDA paves the way for pre-exposure HIV prophylaxis","volume":"380","author":"Holmes","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.annepidem.2021.09.006_bib0004","first-page":"20","article-title":"Descovy approved for HIV prexposure prophylaxis","volume":"120","author":"Aschenbrenner","year":"2020","journal-title":"Am J Nurs"},{"issue":"27","key":"10.1016\/j.annepidem.2021.09.006_bib0005","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.annepidem.2021.09.006_bib0006","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/QAI.0b013e31828ece33","article-title":"Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States","volume":"64","author":"Grohskopf","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9883","key":"10.1016\/j.annepidem.2021.09.006_bib0007","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.annepidem.2021.09.006_bib0008","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.annepidem.2021.09.006_bib0009","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.annepidem.2021.09.006_bib0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"Van Damme","year":"2012","journal-title":"N Engl J Med"},{"issue":"151","key":"10.1016\/j.annepidem.2021.09.006_bib0011","doi-asserted-by":"crossref","first-page":"151ra125","DOI":"10.1126\/scitranslmed.3004006","article-title":"Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men","volume":"4","author":"Anderson","year":"2012","journal-title":"Sci Transl Med"},{"issue":"10013","key":"10.1016\/j.annepidem.2021.09.006_bib0012","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.annepidem.2021.09.006_bib0013","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/cid\/civ778","article-title":"No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting","volume":"61","author":"Volk","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.annepidem.2021.09.006_bib0014","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/QAI.0000000000001129","article-title":"Preexposure prophylaxis for HIV prevention in a large integrated health care system: adherence, renal safety, and discontinuation","volume":"73","author":"Marcus","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"10.1016\/j.annepidem.2021.09.006_bib0015","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/cid\/ciz1229","article-title":"Evidence of an association of increases in pre-exposure prophylaxis coverage with decreases in human immunodeficiency virus diagnosis rates in the United States, 2012-2016","volume":"71","author":"Smith","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.annepidem.2021.09.006_bib0016","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/cid\/ciw701","article-title":"Uptake of HIV preexposure prophylaxis among commercially insured persons-United States, 2010-2014","volume":"64","author":"Wu","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.annepidem.2021.09.006_bib0017","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.annepidem.2018.06.009","article-title":"Trends in the use of oral emtricitabine\/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017","volume":"28","author":"Sullivan","year":"2018","journal-title":"Ann Epidemiol"},{"issue":"12","key":"10.1016\/j.annepidem.2021.09.006_bib0018","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.annepidem.2018.06.005","article-title":"The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States","volume":"28","author":"Siegler","year":"2018","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.annepidem.2021.09.006_bib0019","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.annepidem.2020.03.013","article-title":"Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018","volume":"45","author":"Siegler","year":"2020","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.annepidem.2021.09.006_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.annepidem.2020.07.001","article-title":"Small-area spatial-temporal changes in pre-exposure prophylaxis (PrEP) use in the general population and among men who have sex with men in the United States between 2012 and 2018","volume":"49","author":"Mouhanna","year":"2020","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.annepidem.2021.09.006_bib0021","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.annepidem.2020.01.004","article-title":"Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV epidemic jurisdictions","volume":"44","author":"Sullivan","year":"2020","journal-title":"Ann Epidemiol"},{"issue":"46","key":"10.1016\/j.annepidem.2021.09.006_bib0022","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.15585\/mmwr.mm6446a4","article-title":"Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition\u2013United States, 2015","volume":"64","author":"Smith","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.annepidem.2021.09.006_bib0023","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.annepidem.2018.05.003","article-title":"Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race\/ethnicity, United States, 2015","volume":"28","author":"Smith","year":"2018","journal-title":"Ann Epidemiol"},{"issue":"4","key":"10.1016\/j.annepidem.2021.09.006_bib0024","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11904-019-00447-4","article-title":"Implementation strategies to increase PrEP uptake in the South","volume":"16","author":"Sullivan","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"6","key":"10.1016\/j.annepidem.2021.09.006_bib0025","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1071\/SH18103","article-title":"Getting pre-exposure prophylaxis (PrEP) to the people: opportunities, challenges and emerging models of PrEP implementation","volume":"15","author":"Sullivan","year":"2018","journal-title":"Sex Health"},{"issue":"3","key":"10.1016\/j.annepidem.2021.09.006_bib0026","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.2196\/publichealth.7902","article-title":"Developing a web-based geolocated directory of HIV pre-exposure prophylaxis-providing clinics: the PrEP Locator protocol and operating procedures","volume":"3","author":"Siegler","year":"2017","journal-title":"JMIR public health and surveillance"},{"issue":"9","key":"10.1016\/j.annepidem.2021.09.006_bib0027","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2105\/AJPH.2019.305172","article-title":"Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States","volume":"109","author":"Siegler","year":"2019","journal-title":"Am J Public Health"},{"issue":"12","key":"10.1016\/j.annepidem.2021.09.006_bib0028","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.annepidem.2018.05.006","article-title":"Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States","volume":"28","author":"Siegler","year":"2018","journal-title":"Ann Epidemiol"},{"issue":"11","key":"10.1016\/j.annepidem.2021.09.006_bib0029","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1007\/s10461-018-2184-4","article-title":"Improving PrEP implementation through multilevel interventions: a synthesis of the literature","volume":"22","author":"Pinto","year":"2018","journal-title":"AIDS Behav"},{"issue":"2","key":"10.1016\/j.annepidem.2021.09.006_bib0030","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.2196\/publichealth.4525","article-title":"The effect of commuting patterns on HIV care attendance among men who have sex with men (MSM) in Atlanta, Georgia","volume":"1","author":"Dasgupta","year":"2015","journal-title":"JMIR public health and surveillance"},{"issue":"9","key":"10.1016\/j.annepidem.2021.09.006_bib0031","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1007\/s10461-018-2094-5","article-title":"Travel time to clinic but not neighborhood crime rate is associated with retention in care among HIV-positive patients","volume":"22","author":"Ridgway","year":"2018","journal-title":"AIDS Behav"},{"issue":"4","key":"10.1016\/j.annepidem.2021.09.006_bib0032","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/jrh.12070","article-title":"Geographic access and use of infectious diseases specialty and general primary care services by veterans with HIV infection: implications for telehealth and shared care programs","volume":"30","author":"Ohl","year":"2014","journal-title":"J Rural Health"},{"issue":"4","key":"10.1016\/j.annepidem.2021.09.006_bib0033","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1097\/QAI.0000000000001706","article-title":"Users of a national directory of PrEP service providers: beliefs, self-efficacy, and progress toward prescription","volume":"78","author":"Bratcher","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.annepidem.2021.09.006_bib0034","unstructured":"United States Census Bureau. American Community Survey: Information Guide. 2013. Available at: https:\/\/www.census.gov\/content\/dam\/Census\/programs-surveys\/acs\/about\/ACS_Information_Guide.pdf. [Accessed 11 January 2021]."},{"key":"10.1016\/j.annepidem.2021.09.006_bib0035","unstructured":"United States Census Bureau. Census regions and divisions of the United States. 2018. Available at: https:\/\/www2.census.gov\/geo\/pdfs\/maps-data\/maps\/reference\/us_regdiv.pdf. [Accessed 11 January 2021]."},{"issue":"166","key":"10.1016\/j.annepidem.2021.09.006_bib0036","first-page":"1","article-title":"2013 NCHS urban-rural classification scheme for counties","volume":"2","author":"Ingram","year":"2014","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.annepidem.2021.09.006_bib0037","doi-asserted-by":"crossref","DOI":"10.1007\/s10461-021-03267-z","article-title":"Differences in PrEP awareness, discussions with healthcare providers, and use among men who have sex with men in the United States by urbanicity and region: a cross-sectional analysis","author":"Rossiter","year":"2021","journal-title":"AIDS Behav"},{"issue":"3","key":"10.1016\/j.annepidem.2021.09.006_bib0038","doi-asserted-by":"crossref","first-page":"e25461","DOI":"10.1002\/jia2.25461","article-title":"National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017","volume":"23","author":"Sullivan","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.annepidem.2021.09.006_bib0039","unstructured":"United States Department of Agriculture. Rural America at a glance, 2018 edition. 2018. Available at: https:\/\/www.ers.usda.gov\/webdocs\/publications\/90556\/eib-200.pdf?v=6832.7. [Accessed 11 January 2021]."},{"issue":"41","key":"10.1016\/j.annepidem.2021.09.006_bib0040","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.15585\/mmwr.mm6741a3","article-title":"HIV preexposure prophylaxis, by race and ethnicity - United States, 2014-2016","volume":"67","author":"Huang","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"37","key":"10.1016\/j.annepidem.2021.09.006_bib0041","doi-asserted-by":"crossref","first-page":"801","DOI":"10.15585\/mmwr.mm6837a2","article-title":"Racial\/ethnic disparities in HIV preexposure prophylaxis among men who have sex with men - 23 urban areas, 2017","volume":"68","author":"Kanny","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.annepidem.2021.09.006_bib0042","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/09540121.2013.819403","article-title":"Transportation vulnerability as a barrier to service utilization for HIV-positive individuals","volume":"26","author":"Sagrestano","year":"2014","journal-title":"AIDS Care"},{"issue":"1","key":"10.1016\/j.annepidem.2021.09.006_bib0043","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2105\/AJPH.2019.305309","article-title":"The invisible US Hispanic\/Latino HIV crisis: addressing gaps in the national response","volume":"110","author":"Guilamo-Ramos","year":"2020","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.annepidem.2021.09.006_bib0044","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1037\/a0032694","article-title":"A pandemic of the poor: social disadvantage and the U.S. HIV epidemic","volume":"68","author":"Pellowski","year":"2013","journal-title":"Am Psychol"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279721002908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279721002908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:28:09Z","timestamp":1760927289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279721002908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":44,"alternative-id":["S1047279721002908"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2021.09.006","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The spatiotemporal distribution of pre-exposure prophylaxis accessibility in the United States, 2016\u20132020","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}